ACEPEP
LIVE

Serial Number

99666674

Owner

ACEBIOS INCORPORATED

Filing Date

Feb 24, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ACEPEP Trademark

Serial Number: 99666674

ACEPEP is a trademark filed by ACEBIOS INCORPORATED on February 24, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

ACEBIOS INCORPORATED (2 trademarks)

101 Morgan Lane
Plainsboro, NJ 08536

Entity Type: 03

Trademark Details

Filing Date

February 24, 2026

Registration Date

Not Registered

Goods & Services

Dietary supplemental drinks in the nature of vitamin and mineral beverages; Pharmaceutical products for the prevention and treatment of cancer; Sports cream for relief of pain; Dietary pet supplements in the form of pet treats; Dietary supplements for controlling cholesterol; Dietary food supplements; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Medicated cosmetics; Pharmaceutical preparations for the treatment of hyperlipidemia; Biological preparations for the treatment of cancer; Food supplements, namely, anti-oxidants; Liquid herbal supplements; Pharmaceutical products for treating respiratory diseases; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Natural biomaterials for augmentation of bone and tissue for medical purposes; Gummy vitamins; Powdered nutritional supplement concentrate; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Mineral supplements; Herbal supplements; Vitamins; Cardiovascular treatment preparations; Vitamin and mineral supplements; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Vitamin and mineral formed and packaged as bars; Multi-vitamin preparations; Mixed vitamin preparations; Medicines for the treatment of gastrointestinal diseases; Medicinal herbs in dried or preserved form; Vitamin tablets; Food supplements; Pharmaceutical preparations acting on the central nervous system; Nutritional supplements, namely, carbohydrates in powdered form; Cholesterol reducers; Herbal drinks used to aid in sleep and relaxation; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Weight management supplements; Health food supplements; Nutritional supplement for eliminating toxins from the body; Pharmaceutical preparation for the treatment of gout; Nutritionally fortified beverages for medical purposes; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Calcium fortified candy for medical purposes; Anti-inflammatory and antipyretic preparations; Medicated eye washes; Natural dietary supplements; Antidiabetic preparations; Dietary supplements for humans and animals; Ketone-based meal replacement bars for weight loss purposes; Ketone ester beverages for use as a dietary supplement; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the prevention of osteoporosis; Dietary and nutritional supplements for atherosclerosis; Dietary and nutritional supplements for Alzheimer's disease; Dietary and nutritional supplements for gout; Dietary supplements; Dietary supplements for pets; Dietary supplements for animals; Dietary supplements for human beings; Dietary and nutritional supplements used for weight loss; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Medicinal plant and herb extracts sold as an integral component of medicated cosmetics; Dietary supplements with a cosmetic effect

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 24, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 24, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 23, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 22, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 24, 2026 MAFR
NEW APPLICATION ENTERED
Feb 24, 2026 NWAP